AZD1981   Click here for help

GtoPdb Ligand ID: 7680

Synonyms: AZD 1981 | AZD-1981
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: AZD1981 was an investigational compound being assessed as a potential treatment for asthma. Mechanistically it is a potent, orally active, selective and reversible antagonist of the DP2 receptor (CRTH2).
This compound is now included for repurposing in the AstaZeneca's Open Innovation Pharmacology Toolbox. It was also Case Study (2) in the AZ 2014 review paper [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 96.63
Molecular weight 388.06
XLogP 4.12
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=O)Nc1cccc2c1c(Sc1ccc(cc1)Cl)c(n2CC(=O)O)C
Isomeric SMILES CC(=O)Nc1cccc2c1c(Sc1ccc(cc1)Cl)c(n2CC(=O)O)C
InChI InChI=1S/C19H17ClN2O3S/c1-11-19(26-14-8-6-13(20)7-9-14)18-15(21-12(2)23)4-3-5-16(18)22(11)10-17(24)25/h3-9H,10H2,1-2H3,(H,21,23)(H,24,25)
InChI Key JWYIGNODXSRKGP-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
AZD1981 has completed Phase 2 clinical evaluations in patients with asthma [2,5], COPD [6] and chronic idiopathic urticaria [4]. Click here to link to ClinicalTrials.gov's full list of AZD1981 studies.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
AZD1981 is an antagonist of the prostanoid DP2 receptor and as such blocks the action of prostaglandin D2 at this receptor. The aim of blocking DP2 receptor function is to reduce cellular infiltration in airway tissues, which leads to a decrease in the airway inflammation implicated in asthma pathogenesis.